Deutsche Bank Ag\ Sqz Biotechnologies CO Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.77 - $5.0 $34,228 - $61,785	-12,357 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.01 - $10.42 $112,729 - $292,927	-28,112 Reduced 69.47%	12,357 $59,000
Q4 2021 Feb 11, 2022	SELL	$8.93 - $14.85 $374,202 - $622,274	-41,904 Reduced 50.87%	40,469 $361,000
Q3 2021 Nov 04, 2021	SELL	$11.46 - $15.77 $4,790 - $6,591	-418 Reduced 0.5%	82,373 $1.19 Million
Q2 2021 Aug 11, 2021	BUY	$11.32 - $14.45 $904,954 - $1.16 Million	79,943 Added 2806.99%	82,791 $1.2 Million
Q1 2021 May 13, 2021	SELL	$12.07 - $29.9 $3,331 - $8,252	-276 Reduced 8.83%	2,848 $38,000
Q4 2020 Feb 16, 2021	BUY	$13.25 - $34.58 $41,393 - $108,027	3,124 New	3,124 $91,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.